MWAM
Manhattan West Asset Management’s AbbVie ABBV Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $586K | Buy |
3,157
+236
| +8% | +$43.8K | 0.14% | 95 |
|
2025
Q1 | $612K | Buy |
2,921
+481
| +20% | +$101K | 0.16% | 88 |
|
2024
Q4 | $434K | Sell |
2,440
-208
| -8% | -$37K | 0.12% | 100 |
|
2024
Q3 | $523K | Buy |
2,648
+30
| +1% | +$5.92K | 0.14% | 101 |
|
2024
Q2 | $449K | Sell |
2,618
-26
| -1% | -$4.46K | 0.12% | 104 |
|
2024
Q1 | $481K | Buy |
2,644
+26
| +1% | +$4.74K | 0.12% | 103 |
|
2023
Q4 | $406K | Sell |
2,618
-416
| -14% | -$64.5K | 0.11% | 104 |
|
2023
Q3 | $439K | Buy |
3,034
+333
| +12% | +$48.2K | 0.14% | 104 |
|
2023
Q2 | $364K | Buy |
2,701
+465
| +21% | +$62.6K | 0.14% | 100 |
|
2023
Q1 | $356K | Buy |
+2,236
| New | +$356K | 0.16% | 97 |
|